243 related articles for article (PubMed ID: 21673857)
1. Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries.
Cameron A; Roubos I; Ewen M; Mantel-Teeuwisse AK; Leufkens HG; Laing RO
Bull World Health Organ; 2011 Jun; 89(6):412-21. PubMed ID: 21673857
[TBL] [Abstract][Full Text] [Related]
2. Essential medicines are more available than other medicines around the globe.
Bazargani YT; Ewen M; de Boer A; Leufkens HG; Mantel-Teeuwisse AK
PLoS One; 2014; 9(2):e87576. PubMed ID: 24533058
[TBL] [Abstract][Full Text] [Related]
3. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
Ewen M; Zweekhorst M; Regeer B; Laing R
PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413
[TBL] [Abstract][Full Text] [Related]
4. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis.
Cameron A; Ewen M; Ross-Degnan D; Ball D; Laing R
Lancet; 2009 Jan; 373(9659):240-9. PubMed ID: 19042012
[TBL] [Abstract][Full Text] [Related]
5. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability.
Husain MJ; Datta BK; Kostova D; Joseph KT; Asma S; Richter P; Jaffe MG; Kishore SP
J Am Heart Assoc; 2020 May; 9(9):e015302. PubMed ID: 32338557
[TBL] [Abstract][Full Text] [Related]
6. Availability and affordability of priority life-saving medicines for under-five children in health facilities of Tigray region, northern Ethiopia.
Abrha S; Tadesse E; Atey TM; Molla F; Melkam W; Masresha B; Gashaw S; Wondimu A
BMC Pregnancy Childbirth; 2018 Nov; 18(1):464. PubMed ID: 30497441
[TBL] [Abstract][Full Text] [Related]
7. Access and Affordability of Medicines in Malaysia: Need for a National Pricing Policy.
Wong SL; Ibrahim S; Abdul Kadir N; Mohd Salleh S
Appl Health Econ Health Policy; 2019 Oct; 17(5):641-654. PubMed ID: 31093937
[TBL] [Abstract][Full Text] [Related]
8. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries.
Mendis S; Fukino K; Cameron A; Laing R; Filipe A; Khatib O; Leowski J; Ewen M
Bull World Health Organ; 2007 Apr; 85(4):279-88. PubMed ID: 17546309
[TBL] [Abstract][Full Text] [Related]
9. Availability and affordability of essential medicines for children in the Western part of Ethiopia: implication for access.
Sado E; Sufa A
BMC Pediatr; 2016 Mar; 16():40. PubMed ID: 26979737
[TBL] [Abstract][Full Text] [Related]
10. Prices & availability of common medicines at six sites in India using a standard methodology.
Kotwani A; Ewen M; Dey D; Iyer S; Lakshmi PK; Patel A; Raman K; Singhal GL; Thawani V; Tripathi S; Laing R
Indian J Med Res; 2007 May; 125(5):645-54. PubMed ID: 17642500
[TBL] [Abstract][Full Text] [Related]
11. Availability of Essential Medicines in a Country in Conflict: A Quantitative Insight from Yemen.
Mohamed Ibrahim MI; Alshakka M; Al-Abd N; Bahattab A; Badulla W
Int J Environ Res Public Health; 2020 Dec; 18(1):. PubMed ID: 33383771
[TBL] [Abstract][Full Text] [Related]
12. Availability, prices, and affordability of selected essential cancer medicines in a middle-income country - the case of Mexico.
Moye-Holz D; Ewen M; Dreser A; Bautista-Arredondo S; Soria-Saucedo R; van Dijk JP; Reijneveld SA; Hogerzeil HV
BMC Health Serv Res; 2020 May; 20(1):424. PubMed ID: 32410676
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology.
Saeed A; Saeed H; Saleem Z; Fang Y; Babar ZU
PLoS One; 2019; 14(4):e0216122. PubMed ID: 31022276
[TBL] [Abstract][Full Text] [Related]
14. Prices, availability and affordability of medicines in Rwanda.
Bizimana T; Kayumba PC; Heide L
PLoS One; 2020; 15(8):e0236411. PubMed ID: 32745100
[TBL] [Abstract][Full Text] [Related]
15. Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China.
Yang H; Dib HH; Zhu M; Qi G; Zhang X
Health Policy Plan; 2010 May; 25(3):219-29. PubMed ID: 19955093
[TBL] [Abstract][Full Text] [Related]
16. Comparative performance of private and public healthcare systems in low- and middle-income countries: a systematic review.
Basu S; Andrews J; Kishore S; Panjabi R; Stuckler D
PLoS Med; 2012; 9(6):e1001244. PubMed ID: 22723748
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of rational prescribing and dispensing of medicines in Mali].
Maiga D; Diawara A; Maiga MD
Rev Epidemiol Sante Publique; 2006 Dec; 54(6):497-505. PubMed ID: 17194981
[TBL] [Abstract][Full Text] [Related]
18. Access to essential medicines to treat chronic respiratory disease in low-income countries.
Bissell K; Perrin C; Beran D
Int J Tuberc Lung Dis; 2016 Jun; 20(6):717-28. PubMed ID: 27155173
[TBL] [Abstract][Full Text] [Related]
19. Availability and affordability of antimalarial and antibiotic medicines in Malawi.
Khuluza F; Heide L
PLoS One; 2017; 12(4):e0175399. PubMed ID: 28419126
[TBL] [Abstract][Full Text] [Related]
20. Is the Brazilian pharmaceutical policy ensuring population access to essential medicines?
Bertoldi AD; Helfer AP; Camargo AL; Tavares NU; Kanavos P
Global Health; 2012 Mar; 8():6. PubMed ID: 22436555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
